共 50 条
[1]
Dahlöf B(2005)Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial Lancet 366 895-906
[2]
Julius S(2004)Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial Lancet 363 2022-2031
[3]
Jamerson K(2002)Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288 2981-2997
[4]
Dahlöf B(2008)Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients N Engl J Med 359 2417-2428
[5]
Chow CK(2002)Cardiovascular morbidity and mortality in the Losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Lancet 359 995-1003
[6]
Borghi C(2013)Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries JAMA 310 959-968
[7]
Tocci G(2016)Lack of control of hypertension in primary cardiovascular disease prevention in Europe: results from the EURIKA study Int J Cardiol 218 83-88
[8]
Geldsetzer P(2017)Prevalence and control of hypertension in the general practice in Italy: updated analysis of a large database J Hum Hypertens 31 258-262
[9]
Volpe M(2019)The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults Lancet 394 652-662
[10]
Williams B(2013)2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy High Blood Press Cardiovasc Prev 20 45-52